All change at the top for Boston Scientific
This article was originally published in Clinica
Executive Summary
Boston Scientific has appointed James Tobin as president and CEO with immediate effect, replacing co-founder and CEO Pete Nicholas, who will remain chairman of the company. Mr Tobin was previously president and CEO of pharmaceutical company Biogen. Shares in Boston Scientific leapt 16% to $38.8 on the news.